Obesity is the main determinant of insulin resistance more than the circulating pro-inflammatory cytokines levels in rheumatoid arthritis patients

Obesity is the main determinant of insulin resistance more than the circulating pro-inflammatory cytokines levels in rheumatoid arthritis patients

ABSTRACT Background: Systemic blockade of TNF-α in Rheumatoid arthritis with insulin resistance seems to produce more improvement in insulin sensitivity in normal weight patients with Rheumatoid arthritis than in obese patients with Rheumatoid arthritis, suggesting that systemic-inflammation and ob...

Full description

Bibliographic Details
Main Authors:	Jesus Castillo-Hernandez, Martha Imelda Maldonado-Cervantes, Juan Pablo Reyes, Nuria Patiño-Marin, Enrique Maldonado-Cervantes, Claudia Solorzano-Rodriguez, Esperanza de la Cruz Mendoza, Brenda Alvarado-Sanchez
Format:	Article
Language:	English
Published:	Sociedade Brasileira de Reumatologia
Series:	Revista Brasileira de Reumatologia
Subjects:	Insulin resistance Obesity Rheumatoid arthritis TNF-α
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0482-50042017000400320&lng=en&tlng=en

Similar Items

Proinflammatory cytokines profile in patients with Rheumatoid arthritis
by: Shahlaa M. Saleh, et al.
Published: (2009-04-01)

Estimation levels of CTHRC1and some cytokines in Iraqi patients with Rheumatoid Arthritis
by: Ahmed R. Oleiwi, et al.
Published: (2023-06-01)

An orally available small molecule that targets soluble TNF to deliver anti-TNF biologic-like efficacy in rheumatoid arthritis
by: Alexander Vugler, et al.
Published: (2022-11-01)

Therapeutic effects of Rheumatoid Arthritis on Aspergillosis development
by: Ali AL-Janabi
Published: (2020-03-01)

Influence of rheumatoid factor levels and TNF inhibitor structure on secondary nonresponse in rheumatoid arthritis patients
by: Chamaida Plasencia-Rodríguez, et al.
Published: (2024-09-01)

Corrigendum: An orally available small molecule that targets soluble TNF to deliver anti-TNF biologic-like efficacy in rheumatoid arthritis
by: Alexander Vugler, et al.
Published: (2024-10-01)

Reduction of autophagy and increase in apoptosis correlates with a favorable clinical outcome in patients with rheumatoid arthritis treated with anti-TNF drugs
by: M. Vomero, et al.
Published: (2019-01-01)

Combination of rheumatoid arthritis and sarcoidosis, which had occurred during rituximab therapy, complicated secondary immunodeficiency and intolerance to the main basic drugs: Case repost and literature review
by: O. A. Golovina, et al.
Published: (2021-10-01)

TUMOR NECROSIS FACTOR-α MEMBRANE-BOUND AND SOLUBLE RECEPTORS IN NORM AND IN RHEUMATOID ARTHRITIS
by: A. A. Alshevskaya, et al.
Published: (2012-05-01)

Update on the Pathomechanism, Diagnosis, and Treatment Options for Rheumatoid Arthritis
by: Yen-Ju Lin, et al.
Published: (2020-04-01)

Etanercept in the treatment of Graves’ ophthalmopathy with primary hypothyroidism and rheumatoid arthritis
by: Olivera Boskovic, et al.
Published: (2020-01-01)

Soluble CD14 Induces Pro-inflammatory Cytokines in Rheumatoid Arthritis Fibroblast-Like Synovial Cells via Toll-Like Receptor 4
by: Yoshihide Ichise, et al.
Published: (2020-07-01)

Study on Tumor Necrosis Factor-α· Gene Polymorphism in Rheumatoid Arthritis
by: Kim Kyung-Un, et al.
Published: (2007-06-01)

DYNAMICS OF CYTOKINE PROFILE IN PATIENTS WITH RHEUMATOID ARTHRITIS AS INFLUENCED BY INFLIXIMAB (REMIKEID) ADMINISTRATION
by: E. S. Zhugrova, et al.
Published: (2014-07-01)

Association of neopterin as a marker of immune system activation and juvenile rheumatoid arthritis activity
by: Mones M. Abu Shady, et al.
Published: (2015-07-01)

Radiographic progression based on baseline characteristics from TNF inhibitor biosimilar studies in patients with rheumatoid arthritis
by: Josef S. Smolen, et al.
Published: (2020-08-01)

A Comparative Study to Assess the Efficacy, Safety, and Immunogenicity of YLB113 and the Etanercept Reference Product for the Treatment of Patients with Rheumatoid Arthritis
by: Hisashi Yamanaka, et al.
Published: (2019-12-01)

The first biological choice in patients with rheumatoid arthritis: data from the Moroccan register of biotherapies
by: Meryem Eddaoudi, et al.
Published: (2021-02-01)

The metabolic effects of TNF inhibitors in rheumatoid arthritis patients
by: Alexandra Jitaru, et al.
Published: (2019-12-01)

Association of genetic variation in tumor necrosis factor-? gene with susceptibility to rheumatoid arthritis in southern Iraq
by: Sara H. Jabbar
Published: (2023-04-01)

Imbalance of Pro and Anti-Inflammatory Cytokines in Rheumatoid Arthritis in Iraqi Patients
by: Shakir M. Salih, et al.
Published: (2024-10-01)

Subcutaneously-Administered Infliximab in the Management of Rheumatoid Arthritis: A Short Narrative Review of Current Clinical Evidence
by: Iannone F, et al.
Published: (2022-06-01)

Anti-cytokine vaccination in autoimmune diseases
by: L Delavallée, et al.
Published: (2010-10-01)

Improving dexamethasone drug loading and efficacy in treating rheumatoid arthritis via liposome: Focusing on inflammation and molecular mechanisms
by: Mohammad Yasin Zamanian, et al.
Published: (2025-01-01)

Comparative effectiveness of abatacept versus TNF inhibitors in rheumatoid arthritis patients who are ACPA and shared epitope positive
by: Leslie R. Harrold, et al.
Published: (2024-01-01)

Polyphenols Targeting MAPK Mediated Oxidative Stress and Inflammation in Rheumatoid Arthritis
by: Tapan Behl, et al.
Published: (2021-10-01)

The impact of anti-TNF-α therapy on leptin and inflammatory markers in rheumatoid arthritis patients: a case-control study
by: Mostafa Kaboli, et al.
Published: (2025-02-01)

Biological agents in monotherapy for the treatment of rheumatoid arthritis
by: Cem Gabay, et al.
Published: (2014-04-01)

Reactivation of cutaneous and mucocutaneous tegumentary leishmaniasis in rheumatoid arthritis patients: an emerging problem?
by: Regina Maia de Souza, et al.

Treatment of Cardiovascular Disease in Rheumatoid Arthritis: A Complex Challenge with Increased Atherosclerotic Risk
by: Saba Ahmed, et al.
Published: (2021-12-01)

Maackia amurensis seed lectin (MASL) ameliorates articular cartilage destruction and increases movement velocity of mice with TNFα induced rheumatoid arthritis
by: Kelly L. Hamilton, et al.
Published: (2022-12-01)

Safety of rituximab in the routine treatment of rheumatoid arthritis in Italy in patients refractory to anti-TNFa drugs: results from the observational retrospective-prospective RUBINO study
by: L. Bazzichi, et al.
Published: (2014-11-01)

The Role of Anti-TNFα Therapy in the Amelioration of Disease Burden in Patients with Refractory Rheumatoid Arthritis
by: Madha Mohammed Sheet, et al.
Published: (2014-06-01)

PROMOTER POLYMORPHISM -857С>T OF TNFα GENE AND EFFICACY OF ANTICYTOKINE THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: A. N. Silkov, et al.
Published: (2014-07-01)

Role of Pro- and Anti-Inflammatory Cytokines in Rheumatoid Arthritis: Correlation with Disease Activity.
by: Ahmed A. H. Al-Hassan
Published: (2010-10-01)

Components of the sympathetic nervous system as targets to modulate inflammation – rheumatoid arthritis synovial fibroblasts as neuron-like cells?
by: Xinkun Cheng, et al.
Published: (2023-03-01)

A Three Year Retrospective Analysis Of Anti-Tnf Treatment Outcomes In Rheumatoid Arthritis And Ankylosing Spondylitis Patients
by: İrem Bilgetekin, et al.
Published: (2020-09-01)

Influence of TNF-α inhibition on oxidative stress of rheumatoid arthritis patients
by: F. Cacciapaglia, et al.
Published: (2016-02-01)

The plasma Tumor Necrosis Factor-α (TNF-α) does not have any correlation with disease activity in rheumatoid arthritis patients treated with disease modifying anti-rheumatic drugs (DMARDs)
by: Zahra Samimi, et al.
Published: (2020-12-01)

The Role of Serum Chitinase-3-Like 1 Protein (YKL-40) Level and its Correlation with Proinflammatory Cytokine in Patients with Rheumatoid Arthritis
by: Noor Ulhuda G. Mohammed, et al.
Published: (2022-10-01)